Anal fistula occurs most commonly when the anal glands, which reside in the intersphincteric plane, become occluded and infected, which results in a cryptoglandular abscess. Whether surgically or spontaneously drained, a perirectal abscess may still result in fistula in up to 40% of cases; however, spontaneously draining abscesses tend to have a higher rate, up to 66%, of fistula formation. The mean incidence has reported at 8.6 per 100,000. The presence of acute or chronic anal fistula can be distressing for patients and cause reduced quality of life. They are commonly classified based on their anatomical locations, first described by Parks, Gordon, and Hardcastle, in 1976.
Understanding anorectal anatomy, as well as the classifications of perirectal fistulas, is paramount in their management.
Classification of Anorectal Fistulas
Anorectal fistulas are characterized by their tract location relative to the internal and external sphincters.
Parks and Gordon
Inevitably, as most abscesses develop in the place between these sphincters, the most common type is an intersphincteric fistula. That is one that crosses the internal sphincter and then has a tract to the outside of the anus leading. A fistulotomy efficiently manages these, or laying open of the fistulous tract and rarely cause incontinence as the treatment does not affect the external sphincter. Intersphincteric fistulas are the most common type of fistula comprising 50-80% of all cryptoglandular fistulas.
Trans is a Latin word for “on the other side of.” So a trans-sphincteric fistula is one that crosses to the other side of the external sphincter before exiting in the perianal area and thus involving both sphincters. Transsphincteric fistulas represent a challenge in management because of this and often require more complex or staged treatment. However, the use of a seton to gradually “lower” the tract and make the tract less involved with the external sphincter may allow migration of the tract and a fistulotomy at a later date while preserving the continence of the patient. The extent of involvement of the external sphincter dictates the likelihood of postoperative incontinence as a partial sphincterotomy will usually be tolerated. Still, if the fistula involves the majority of the sphincter, then incontinence will result after a complete division.
These fistula tracts travel superior to the external sphincter and cross the puborectal muscle before changing course caudal to their external opening. Accordingly, they pass the internal sphincter and the puborectal muscle but spare the external sphincter. When these patients typically present with a perirectal abscess, it may not be visible on inspection, but they will have tenderness on the digital rectal exam. Again, because of their high tract, the use of a seton may be considered in these cases before fistulotomy. A fistulectomy is similar to fistulotomy but involves removal of the entire fistula tract either sharply or with cautery. Historically radical fistulectomy was the standard treatment for anal fistula; however, fistulotomy tended to be preferable as it preferred more sphincter function, was a less morbid procedure, and healed faster. However, more recently, with specialists performing the majority of fistula procedures, it seems the outcomes of fistulectomy and fistulotomy are similar. A recent meta-analysis published in 2016 of six randomized controlled trials (RCTs) of fistulectomy versus fistulotomy in low fistulas demonstrated no significant difference in recurrence in five RCTs and no significant difference in postoperative incontinence in four RCTs.
These fistulas often arise in the more proximal rectum rather than the anus and are often sequelae of a procedure. Their external opening is in the perianal area and the tract courses superiorly to enter the anal canal above the dentate line.
St James University Hospital (SJUH) Classification (Imaging-based classification)
The SJUH is an imaging-based classification that has five grades based on the anatomic location of fistulas. MRI is more sensitive at delineating soft tissue than CT and has proven to be a reliable method of characterizing the anatomy of anorectal fistula preoperatively as it provides excellent images of the sphincter complex as well as fat in perirectal and supra-levator spaces allowing preoperative identification of involvement of these regions. Furthermore, because MR has multiple potential axial planes, it will enable identification of the internal opening of anal fistulas more readily than other imaging modalities.
A paper published in 2000 by Morris et al. first described the SJUH classification, which is based on MRI findings. Grade 1 fistulas are “simple linear intersphincteric fistula,” which is the same as the “intersphincteric” Parks classification. A grade 1 fistula with the presence of concomitant abscess or an additional fistulous tract is a grade 2 Fistula. Traversement of the external sphincter denotes a grade 3 fistula, which is also known as a trans-sphincteric fistula. A trans-sphincteric fistula with an abscess or an additional tract in the ischiorectal fossa is classified as a grade IV. In contrast, a supra-levator or trans-levator fistula is denoted as grade V. This classification, based on MRI findings of the pelvis, provides an objective preoperative assessment for the surgeon. The diagnostic utilization of MR imaging classification is more predictive of surgical outcome than intraoperative findings.
In general, grade 1 and grade 2 fistulas can be readily managed with fistulotomy or fistulectomy. If an abscess is present in grade I or 2, an incision and drainage should be performed. If a fistula remains after the acute infection resolves, management is then based on the type of fistula present. Grade 3 and 4 involve the external sphincter, so placement of seton may be necessary before fistulotomy or a more specific procedure such a ligation of intersphincteric tract (LIFT) procedure or endoanal advancement flap may be required. Grade 5 fistulas are often indicative of an atypical etiology of the fistula, and further workup and diagnostics should be performed before an operation. Treatment of fistulas in Crohn disease is discussed briefly below but should always be done in the context of the treatment of the underlying condition.
A multitude of causes cause fistulas, but the well-known mnemonic "FRIEND" here aids memory. "F" for foreign body, "R" radiation, "I" infection or Inflammatory Bowel Disease, "E" epithelialization, "N" neoplasm, and "D" for distal obstruction (as is the case in the cryptoglandular theory).
Foreign bodies in the rectum often are those placed intentionally, such as a seton to lower a fistula tract and make it more localized and aid healing. Radiation causing fistulas are well known and will be discussed briefly later on in this article.
Infection is the most common cause of anorectal fistula and is thought to originate from a blockage of the anal glands and crypts. The two anal sphincters are divided by an avascular fatty areolar plane, which provides means for the spread and infiltration of an infection. Often an abscess will develop in this region, and it will find a way to drain via a fistula spontaneously. Obstruction of the anal glands allows bacteria to proliferate and ultimately forms a perirectal or anorectal or perianal abscess. With or without surgical treatment of the anorectal abscess, there is a significant risk of fistula formation. In addition to an incision and drainage, a 5 to 10-day course of antibiotics has been shown to decrease the rate of fistula formation.
A thorough understanding of anorectal anatomy is critical to understanding abscess-to-fistula development. The correct localization of the fistula relative to the sphincters is vital to correct operative management. The essential structures in the anorectal region include the rectum itself, anal glands, anal sphincters, the levator ani, which is comprised of the puborectalis, pubococcygeus, and iliococcygeus. The anal canal lining is composed of stratified squamous epithelium distally, which changes to squamocolumnar epithelium proximally past the dentate line. Proximal to the dentate line is where the columns of Morgagni appear, which are folds of columnar glandular epithelium.
Anal fistulas are rarely a presentation of anal tuberculosis and should be suspected in endemic regions or nonhealing recurrent fistulas. Utilizing the polymerase chain reaction of pus samples is more sensitive than histopathology in testing for tuberculosis. Anal fistulas in a younger patient, particularly if they are complex fistulas or multiple, should raise suspicion for Crohn disease.
Sexually transmitted infections (STIs) of the anus and rectum, usually secondary to anal receptive intercourse, may predispose individuals to perianal abscess and fistula. These anorectal STIs are most commonly caused by gonorrhea, chlamydia as well as, syphilis (Treponema pallidum) and herpes simplex.
Radiation proctitis is another cause of anal fistulas. Radiation proctitis requires surgical intervention in less than 10% of the cases with fistula tracks to the vagina, urethra, and bladder being a common complication. Impaired microvascular healing often requires multiple treatment modalities, including local excision, flap reconstruction, and diversion of stool or urine from the site. Patients with human immunodeficiency virus, with or without AIDS, are predisposed to anorectal disease and anal fistulas. These fistulas may lack internal openings and are sometimes in the absence of an underlying abscess. In one study, fistula-in-ano accounted for 6% anorectal pathologies in HIV patients and was irrespective of the utilization of antiretroviral therapy.
Complicated vaginal deliveries with 3rd or 4th-degree tears or requirement of episiotomy may predispose to anal fistula; however, these fistulas often heal spontaneously. In nonhealing obstetric related anal fistulas, surgical therapy is dependent on the location of the fistula as well as vaginal involvement. When distal to the dentate line, a recto-vaginal fistula becomes an ano-rectovaginal fistula. Causes include obstetrical trauma typically associated with a traumatic vaginal birth. Patients who undergo episiotomy are at increased risk for sphincter injury and fecal incontinence.
Although the majority of the resting anal tone is attributed to the involuntary internal sphincter, the external sphincter is vital to maintaining fecal continence and is comprised of striated voluntary muscle fibers. Three nerve branches innervate it; the external perineal nerve anteriorly, the inferior rectal nerve posteromedially, and in 31% of cases, an additional posterior branch arising from either S4 or the inferior rectal nerve.
An anorectal fistula is relatively uncommon and has an incidence of 1-8 per 10,000 persons every year. In the western hemisphere, up to 25% of cases may be associated with Crohn disease. It is two times more common in males than females and usually presents in the 3rd to 5th decade of life. Some risk factors for perirectal fistula include obesity, diabetes, hyperlipidemia, history of anorectal surgery, and even excess salt intake.
Smoking has also been associated with perianal abscess and fistula development and recurrent anal fistula in certain procedures. Patients that are younger than age 40 or who have recurrent anal abscesses may be predisposed to the development of an anal fistula.
An anal fistula, which is an epithelialized connection between the anal canal and external peri-anal area, is characterized by inflammatory tissue and granulation tissue. The distal obstruction prevents the fistula from healing. Because cells are continually being turned over, there is constant debris in the fistula tract, which causes obstruction and prevents healing. The use of a seton and how it allows fistulas to heal is evidence of this as setons allow constant drainage of the fistula and usually result in the fistula migrating and healing.
Histologic analysis of fistula tissue should be sent when an atypical etiology, such an infectious or malignant etiology, is suspected. In general, tissue from anal fistula surgery is not usually sent for pathologic analysis as it does not contribute to the management unless there is an occult process. A study of 84 patients treated for anal fistula evaluated the yield of histopathological analysis in the routine assessment of tissue from anal fistula surgery found a low positive for this tissue except in the setting of a recurrent fistula or when HIV, tuberculosis or Crohn disease was suspected. The majority of fistula pathology simply demonstrates a fistula tract. In cases of Crohn disease, noncaseating granulomas may be seen, and if tuberculosis is present, then an acid-fast bacilli test is helpful to aid diagnosis.
A thorough history, complete review of systems, and physical exam are essential for determining the cause of fistula in patients who have not recently had a perirectal abscess drained. Patients with inflammatory bowel disease may be tender on an abdominal exam and provide a history of bloody diarrhea, abdominal pain, or systemic symptoms such as weight loss or fever. A complete sexual history is vital as lymphogranuloma venereum can, in some instances, cause a perianal fistula.
A history of malignancy or radiation to the pelvis is essential as fistulas from radiation are well documented, and treatment should be coordinated with the patient’s cancer care. A history of rash or multiple new sexual partners should prompt suspicion for syphilis. A patient with a chronic cough or a history of tuberculosis could present with the disease as an anorectal fistula, particularly if he or she is from an endemic region. Multiple draining fistulas, fistulas in abnormal locations, and fistulas that are chronic or recurrent should raise concern for a systemic process.
Typical complaints include itching, drainage, discomfort, and possible pain with defecation on presentation. Patients that had an abscess that was inadequately drained may present with a fistula and recurrent perianal abscess. The surgical and procedural history is vital as a history of anorectal procedures is associated with the development of an anorectal fistula.
A perianal exam and anoscopy in the office are necessary for the evaluation of concurrent abscess, assessing external fistulous opening and other anorectal diseases such as fissure or hemorrhoids. On inspection, a small opening outside the anus with or without visible drainage may be seen. The drainage may be serous, serosanguinous, bloody, purulent, or fecal matter depending on the location of the fistula. Around the opening, there may be hypertrophied tissue, which is suggestive of a developed tract; this is sometimes palpated on the digital rectal exam. The digital rectal exam is also essential to assess for any tenderness, which suggests occult abscess.
Anoscopy may reveal the internal opening; however, usually, an exam under anesthesia is necessary to find the internal opening of the fistula. Cutaneous openings which lie anterior, or ventral, to transverse anal line typically are connected to the anal canal via a radial tract according to Goodsall’s rule. While his rule states openings posterior or dorsal to this transverse anal line will appear posteriorly internally. Perianal skin may have irritation from chronic drainage, and patients often complain of having to wear pads or change their underwear frequently during the day.
Imaging: An anorectal fistula is a clinical diagnosis, but imaging is beneficial in determining the course of a fistulous tract or determining its etiology. Imaging studies include endo-anal ultrasound, CT pelvis, CT-fistulography, and MRI of the pelvis.
Endorectal ultrasound is also a useful modality to assess for an abscess with similar sensitivity but less specificity than MRI. The introduction of hydrogen peroxide into the external fistulous opening canal improves the accuracy of endoanal ultrasound in identifying both fistulous tracts and occult abscesses and may be equivalent to anal MRI in the diagnosis of fistulous tracts. It is a less expensive modality than MRI and may be done in the office, facilitating its use for patients with chronic fistula such as Crohn disease patients who require long term follow up.
CT scan and CT Fistulogram
Computerized tomography is useful for identifying abscesses and drainable fluid collections, as is quick and readily accessible in the majority of clinical scenarios. Although it is not as sensitive or specific as pelvic MRI for classification of anal fistulas. In the clinical setting where an acute infection of an anal fistula or an underlying abscess is suspected, and timely diagnosis is needed, a CT scan may be the most appropriate imaging to expedite diagnosis and treatment for a patient.
In the outpatient setting, CT-fistulography is a useful and efficient modality for identifying fistula tracts preoperatively. However, it requires expert radiologists to read the images as well as a skilled surgeon being available to inject the contrast for the exam. It may be a cost-saving when compared to MRI. It should be considered in complex anal fistula preoperative planning when trying to save costs or in patients who are reluctant or unable to undergo an MRI. Multidetector CT has been utilized with similar efficiency in identifying fistulous tracts as well as underlying abscesses.
Magnetic Resonance Imaging (MRI)
MRI of pelvis assists in the identification of fistulous tracts and occult abscesses as well as characterizing proximity of tracts to the internal and external sphincters to coordinate effective planning. Although CT pelvis is useful for the evaluation of underlying abscess, it is less sensitive than MR in identifying fistulous tracts. MRI has been shown in different studies to aid operative planning and reduce fistula recurrence or need for various operations as it allows the surgeon to identify occult fistulous tracts and plan for a more extensive procedure when necessary.
MRI is a compelling preoperative tool, particularly in complex fistulas and those with an external opening greater than 2 cm from the anus. MRI is very sensitive and specific in diagnosing fistulous tracts and characterizing their internal and external openings. In a study by Garg et al. of 229 patients, the use of MRI changed the preoperative diagnosis in half of simple and over a third of complex fistulas.
It is efficacious in identifying post-operative complications such as an abscess or recurrent fistula, particularly at or after 12 weeks postoperatively. In complex fistulas, the utilization of a balloon rectal channel catheter improves the accurate identification of internal openings. Buchanan & colleagues found the usage of MRI to plan surgery was associated with decreased recurrence of fistulas by facilitating a complete initial operation. In a case-controlled study of 41 patients comparing CT-fistulography to MR preoperatively, internal openings were more readily identified by MRI than CT-fistulography (85.3% vs. 68.2%); the combination of both imaging modality findings in patients was most consistent with operative findings.
Basic laboratory panels should be obtained in patients, including complete blood count and comprehensive metabolic panel. Low hemoglobin may reveal underlying anemia, which could be secondary to an inflammatory bowel disease or gastrointestinal malignancy. Leukocytosis may reveal an underlying infectious process or occult abscess, as well as an elevated C reactive protein. Other blood tests for inflammatory bowel disease, rapid plasma reagin, and others.
Current Management Options for Anorectal Fistula
Treatment Options for Anorectal Fistula
The treatment for a fistula depends on etiology. Still, in general, an exam under anesthesia is typically indicated to identify the fistulous tract using a lacrimal probe and methylene blue or hydrogen peroxide. When the fistulous tract is detected if the cause is known to be an abscess or otherwise, there have been excellent results with a fistulotomy on the initial operation, which is shown to decrease the need for additional procedures.
Fistulotomy Versus Fistulectomy
A fistulotomy is the gold standard for an acute anal fistula and entails first identifying the tract of the fistula using a probe. The patient is placed in a lithotomy or prone jackknife position. Deep sedation or general anesthesia is used. The anus and perianal area are prepped with betadine. A local anesthetic is injected at the start of the procedure, which helps decrease postoperative pain and may help separate tissue planes. A digital rectal exam is performed. A Lonestar retractor or a Park's retractor is placed. The fistula tract is identified by probing the external opening using a lacrimal probe. Then an injection of methylene blue and or hydrogen peroxide into the external opening using a small angio-catheter will reveal the internal opening and if there are multiple internal openings. Keeping the probe through the external and internal openings, the sphincters are carefully identified, and their involvement is assessed. If the external sphincter is not involved, a fistulotomy is performed. Division of the external sphincter should be avoided at best to preserve continence; however, if a necessary division of the lower segment is associated with acceptable postoperative continence rates.
Being careful to avoid the external sphincter and simply splaying open the fistulous tract using a Bovie cautery or sharply. Electrocautery is then used to obliterate the epithelialized tract as much as possible, and the wound is left open to heal. Fistulotomy healing rates have been reported as high as 94% in some series.
A newer procedure that is utilized for high transphincteric or supra-sphincteric fistula is fistulectomy with sphincter reconstruction. In this procedure, the sphincter is divided where the fistula tract is, and after excision of the fistula tract, the sphincter is re-approximated with absorbable sutures. Recent studies have shown promising results with this technique for high and complex fistulas with healing rates approaching 90% and incontinence of 2%. Further utilization of this technique and studies on outcomes is necessary to expand its usage.
When compared to other operations, fistulotomy is associated with higher healing rates and less need for additional surgeries. Fistolotomy has been historically known as the gold standard as therapy for a fistula; however, its utilization varies. It has excellent first time healing rates. Results of fistulotomy versus fistulectomy are variable with some studies favoring fistulotomy over fistulectomy because of faster healing time but similar complication rates. Fistuolotomy with marsupialization has been associated with shorter duration of wound discharge and decreased healing time as compared to fistulectomy by significantly decreasing wound size. It also may decrease bleeding rates. A study utilizing endoanal ultrasound to assess internal and external sphincter lengths postoperatively found the injury to the sphincter mechanism occurred more often during fistulectomy versus fistulotomy.
A meta-analysis of six randomized controlled trials comparing the two showed no significant difference in healing rates or postoperative complications. In patients undergoing fistulotomy, a sphincter sparing approach may yield improved functional outcomes. Recurrence of fistula-in-ano after a fistulotomy is performed usually seen within 12 months after the index operation. Patients who are at high risk for postoperative incontinence, such as females, patients with prior history of anorectal procedures, pre-existing poor sphincter control, should be considered for a sphincter sparing procedure. Complex fistulas, while amenable to fistulotomy and fistulectomy, may be associated with poorer outcomes as for a trans-sphincteric fistula division of the sphincter is necessary for an adequate fistulotomy or fistulectomy. Performing preoperative anal manometry is a useful tool for predicting postoperative functional outcomes as well as guiding the type of fistula surgery to minimize sphincter related complications. In an international survey of surgeons who treat anal fistula, 80% considered fistulotomy as the gold standard.
Seton-Primary Drainage of the Fistula
Seton placement works by the simple concept of allowing a fistula to adequately drain so that healing by secondary intention, from internal to external, may occur. A seton may be placed in the operating room once both the internal and external openings of a fistulous tract are known, and the tract is probed with a lacrimal probe. By allowing the tract to drain and having the seton in place continuously, the tract will slowly migrate from a deeper or higher space to a more superficial location. There are various kinds of setons, mainly simple setons, which may be a small vessel loop that is placed loosely. Setons may be used as the primary treatment for a fistula or as a staged procedure, and the patient return to the operating room for a fistulotomy after their high fistula has converted to a low fistula.
For a cutting seton, a suture is placed and is tied snugly to encourage the migration of the tract. As the wound migrates, the seton becomes loose, and it is then tied again more snugly in the office at intervals. A loose seton, typically a vessel loop, the patient may regularly turn to assist the healing, and these are effectively similar to cutting setons. Setons are an effective definitive therapy for high trans-sphincteric fistulas with complete healing rates up to 98%. They can also be used as effectively as a staged procedure. Setons are highly effective in Crohn disease patients as well.
In an extensive study of 372 patients in Saudi Arabia with high anal fistula, the combination of cutting seton, an 0-silk suture-0, placed after a partial fistulotomy had exceptional healing rates of 97% with no fecal incontinence and a low recurrence 2.4%. In a study of high trans-sphincteric fistulas in the US, the daily rotation of a silk suture seton by the patient was an effective means for treating the high fistulas with zero patients having incontinence of stool. Of patients with high trans-sphincteric fistulas treated with setons, recurrent fistula, supra-levator extension, or the presence of horseshoe fistula have a higher propensity for recurrence. Setons have also been shown to be successful in supra and extra-sphincteric fistulas. Advantages are the preservation of the sphincter, the ability to treat high or complex fistulas with a simple technique. Preserving the internal sphincter intraoperatively may further decrease rates of incontinence postoperatively. Setons have been shown to have significantly higher healing rates than treatment with fibrin glue.
Some disadvantages of setons are that they require frequent follow-up, are cumbersome for the patient, might be uncomfortable for patients, and have long healing times, which can be up to 6 months or, in some cases, longer. In a study of 55 patients who failed seton therapy for their fistula, an endorectal advancement flap had superior short term results than a LIFT.
Ligation of Intersphincteric Fistula Tract (LIFT)
The LIFT procedure was first described by Rojanasakul & colleagues in 2007, in which 18 patients with intersphincteric fistulas were successfully treated using this novel technique. The method involves identifying the intersphincteric groove (ISG), identifying the internal and external openings of the fistula, followed by careful dissection of the portion of the fistula tract within the intersphincteric groove. The dissection can be carried out using cautery and or small scissors. Once the tract is dissected and is clamped with a right angle clamp, it can be safely suture ligated within the ISG close to the internal sphincter while preserving the integrity of both the internal and external sphincter musculature. It is then ligated with an absorbable suture. Distal to its ligation the tract is sharply divided, and this is confirmed with an injection of saline or hydrogen peroxide through the external opening. Any remnant of the intersphincteric tract is carefully removed, and finally, a small incision on the external opening is made to facilitate drainage. The wound over the ISG is precisely approximated with a few simple absorbable sutures. The LIFT procedure can also be safely performed using a lateral approach with acceptable outcomes of up to 75% healing rates.
This technique is specific for trans-sphincteric fistula tracts. Still, it can also be utilized for other complex fistulas that have a tract through the ISG, such as horseshoe or supra-sphincteric fistulas.
LIFT is an effective surgical modality for high and complex anal fistulas with healing rates ranging from 40-100% and very low or absent sphincter dysfunction with larger cohorts demonstrating first time healing around 75% of the time. Failures of the operation are usually attributed to incorrect identification of the intersphincteric portion of the fistula tract. In a systemic review and meta-analysis of which included 1295 patients comparing LIFT to anal advancement flap, there was no significant difference in cure rates in both cryptoglandular and Crohn disease-associated fistulas; however, the LIFT had better continence preservation. Both groups had acceptable cure rates in 61% of Advancement flap patients and 53% of LIFT patients.
Some cons of the LIFT is the potentially high recurrence rates reported in studies approaching 40%.
Benefits of the LIFT procedure are the ability to operate on patients with previous fistula surgeries, preservation of continence, small incision, and scar, and the method is compatible with re-operation if needed. Patients with a history of multiple fistula surgeries, a longer fistula tract, smokers, or those with obesity are at higher risk for failure of the operation.
Advancement Flap for Anal Fistula
Advancement flap for anal fistula is one of the earlier techniques for treating complex anal sphincters that has remained an important surgical option through the years despite many variations in technique and combinations of this technique with others. Rectal advancement flap or mucosal advancement flap, this procedure is commonly performed using rectal mucosa coverage of the internal opening of the fistula after coring out of the fistula tract. Usually, the external opening is left open to drain. It has been shown to have acceptable healing rates with low recurrence in <10% of patients and is a viable option for patients who have had prior fistula surgeries. The shape of the endorectal flap, which can be elliptical or rhomboid, does not appear to affect outcomes. For higher or more proximal fistulas, a trans-anal approach, or TAMIS (transanal minimally invasive surgery), can be utilized successfully to allow easier and more extensive mobilization of a long rectal flap. Compared to seton placement, RAF may have a lower recurrence and wound infection rates. Partial or full thickness flaps are superior to mucosa only flaps in some studies with lower failure rates. This is generally attributed to the improved blood supply of the flap as the underlying circular smooth muscle contains significant vasculature.
Despite usually high rates of fistula recurrence in Crohn disease patients, RAF is another treatment option for these patients, provided there is adequate drainage before the flap procedure. Crohn disease patients treated with immunologic seems to have improved outcomes with this operation. Smoking is associated with failure of advancement flap repairs, and with recurrence of the fistula, horseshoe fistula is associated with failure. There are multiple variations of advancement flaps published in the literature with the type necessary determined by the type of fistula present. For instance, rectal advancement flap, in combination with sphincteroplasty, has been effectively utilized for the treatment of rectovaginal fistulas secondary to obstetric procedures.
Anal Fistula Plug:
An anal fistula plug is another sphincter sparing procedure which can be utilized in patients with a high risk of incontinence or complex fistulas. Plugs can be made of fibrin, porcine, or other biologic absorbable materials. Adequate drainage of the fistula must take place before placing any foreign body to minimize the risk of anal sepsis. For the fistula plug surgery, the internal and external opening of the fistula is first identified, and a probe is placed through them. This is sometimes followed by a mini-debridement of the track using a "fistula brush" or curette. A suture is easily pulled through the track, and the plug threaded through it.
The plug is sutured in place in the internal opening to the mucosa and the internal anal sphincter such that mucosa covers it entirely. In contrast, the external fistula opening is left open to drain. Anal fistula plugs have been widely controversial, with studies being inconsistent in outcomes. A large randomized control trial of fistula plug versus surgeon preference for transphincteric fistula in the United Kingdom found similar healing rates but with higher cost in the anal plug group, with no difference in the fecal incontinence, quality of life scores between the two groups. Healing rates for complex fistulas treated with anal fistula plug as a primary therapy range 13-60%, with most studies quoting around 55%. They tend to have higher recurrence rates of fistula than other surgeries for anal fistula as well. In a randomized controlled trial comparison of fistula plug versus mucosal advancement flap, the fistula plug had recurrence rates 66%. Besides lower healing rates, absorbable fistula plugs have been associated with postoperative anal sepsis. Studies in favor of anal fistula plugs have shown cost-effectiveness when compared to endoanal advancement flap repair but in a small sample. In a randomized controlled trial of 104 patients with Crohn disease, anal fistula plug was not superior to the removal of seton. Because the results of studies have varied widely, it is still recommended in some international guidelines for the treatment of Crohn disease anal fistulas and recognized as a treatment option for these patients by the ASCRS guidelines.
Video-Assisted Anal Fistula Treatment (VAAFT)
Video-Assisted Anal Fistula Treatment of VAAFT is an emerging modality for the treatment of anal fistulas. It involves placing a tiny endoscope, a "fistuloscope," through the external opening of the fistula tract and the tract is explored for its internal opening. Any contiguous tracts or abscesses are identified. Diathermy is used to obliterate the tract under direct visualization, and, similar to plug therapy, the tract is debrided with a brush. The internal opening, once localized, and after debridement, is closed with sutures. In one study of 73 patients treated for complex cryptoglandular fistulas, VAAFT was associated with decreased pain, length of stay, and wound secretion and was able to be repeated safely for patients who failed initial VAAFT. Further studies will provide more insight into this novel technique.
Anal Fistula in Crohn Disease
Fistulizing disease in Crohn patients is a severe disease to treat, but early recognition and diagnosis are critical to effective therapy. These patients should be referred to a gastroenterologist and receive anti-TNF alpha therapy as their primary treatment for fistula disease. After medical treatment, if the fistula persists, setons are the most commonly used primary surgical option in these patients with reasonable healing rates after anti-TNF alpha therapy. Crohn disease patients often are misdiagnosed and have delays in care and also may experience prolonged waiting periods to obtain their medications; thus, a comprehensive care team may be more effective in the management of these patients. Infliximab is the primary treatment for these patients. In patients receiving infliximab therapy, higher blood levels of the drug have been associated with improved healing rates. Patients with Chron disease are likely to have concomitant proctitis, which is revealed by preoperative imaging. A study of 126 patients with anal fistulas who underwent preoperative MRI found that MRI findings of concomitant rectal inflammation were more closely associated with Crohn disease.
The International Organisation for Inflammatory Bowel Diseases (IOIBD) global consensus guidelines emphasize the importance of evaluation of the rectum in these patients as their disease may often affect the rectal mucosa and anorectal area simultaneously. In a study of 36 pediatric and adult patients with fistulizing Crohn disease, a cutoff of 2.5 cm seen on MRI predicted patients who responded to infliximab therapy and those with the persistence of illness. A few studies have shown effective healing rates around 67-90% of combined seton and anti-TNF alpha therapy in Crohn disease patients that were retrospective in nature. A large meta-analysis comparing healing of primary seton versus infliximab failed to determine which was superior as the studies varied in outcomes.
The differential diagnosis for anal fistula includes firstly all of the common anorectal conditions seen in a primary care providers office or that of a general or colorectal surgeon.
In addition to these, there are infectious, benign, and malignant processes which may present as or appear as an anal fistula such as
Prognosis of the anorectal fistula is variable depending on etiology. In anal fistulas of cryptoglandular origin healing rates for simple fistulas approach 80%, and that of complex fistulas are around 60% for sphincter preserving operation. Setons have been used with much success up to 80 to 90% healing rates, but these are healing rates measured after six months. In general, a fistula that is treated with a fistulotomy or fistulectomy, depending on the wound size, should be entirely healed by 12 weeks. If drainage is increased or persistent up the twelfth week that the fistula recurred or did not close completely. Causes for failure of surgical therapy include incomplete division of the fistula in a fistulotomy or incomplete resection or obliteration of tract in a fistulectomy. In the LIFT procedure, leaving a long fistula tract behind and incomplete ligation of the fistula tract are possible causes of failure. In anal-cutaneous or rectal mucosal advancement flap techniques, if the flap fails, the fistula will either not heal or will recur. Smoking is a risk factor for failure of treatment with flap, as well as Crohn disease. This is often secondary to the inadequate blood supply of the flap, as evidenced by improved healing rates when the muscular layer is used in the flap.
Failure of anal fistula plugs to allow fistulas to heal can be attributed to multiple reasons including, not completely covering the plug internally, incomplete debridement of the fistula tract, and premature dislodgement of the fistula plug. Setons that are removed too early may lead to the fistula not healing if the tract has not migrated sufficiently to allow the fistula to heal. Some setons may lead to a lower fistula that then requires a fistulotomy for complete healing to occur.
Depending on the initial procedure performed, additional procedures are used to treat recurrence fistula. When a fistula recurs, an MRI is helpful to determine its course, and an exam under anesthesia should be performed to characterize the fistula tract. Treatment is based on the type of fistula present, which may be different on recurrence than on complex fistula. Because the risk of incontinence is increased with repeated anorectal surgeries, a sphincter preserving approach is best utilized in the treatment of recurrent fistula, mainly if a fistulotomy or fistulectomy was the primary treatment. LIFT procedure is an option for recurrent fistulas. A failed LIFT procedure may be followed by a repeat LIFT procedure or an advancement flap procedure or seton. One study which evaluated outcomes of 53 patients who failed LIFT procedure and went on to undergo an endorectal advancement flap or fistulotomy staged with seton showed a 50% healing rate. Of patients with a high transphincteric fistula, those with a horseshoe extension of the fistula may have improved success with anal advancement flap repair.
Setons used as the primary treatment should be considered a staged procedure and followed by a fistulotomy. Anal fistula plug procedure that has failed may be followed by a seton, advancement flap, LIFT, or even fistulotomy depending on the location of the fistula. A failed flap may be repeated using tissue from a different site. VAAFT is a safe treatment option when repeated for failed initial VAAFT with increased healing rates on the repeat procedure.
Complications of anal fistula surgery are
A large meta-analysis examined risk factors for recurrence of anal fistula after fistula surgery included a high transanal fistula, horseshoe extensions, and multiple fistula tracts as well as the patient having a history of anal procedures or not identifying the internal opening of the fistula intraoperatively. In a study of 251 patients who had high transphincteric fistulas and were treated with loose setons history of fistula surgery, horseshoe fistula, and anterior fistula were risk factors of recurrence.
Risk Factors for fecal incontinence after fistula surgery include a history of anorectal procedures, female gender, complex fistulas, and preoperative incontinence. Fistulotomy should be avoided in fistulas, which are grades 3 or 4 as complex fistulas are associated with higher rates of postoperative incontinence. Performing anal manometry can be helpful preoperatively in determining which patients should undergo a sphincter sparing approach as patients that exhibit signs of incontinence before surgery are more likely to have worsened function postoperatively. A history of incisions and drainage or multiple fistula surgery is associated with a higher risk of worsened postoperative sphincter function as well as the type of operation performed, a fistulotomy, or a sphincter sparing procedures.
Female sex is a risk factor for postoperative incontinence. Treatment of incontinence to flatus and stool involves biofeedback therapy, sacral nerve stimulation. A systematic approach to fecal incontinence has been proposed with initial treatment consisting of bulking agents for stool and increasing dietary fiber followed by training of the pelvic floor muscles with biofeedback therapy. If these are not effective, then more invasive options, including surgical sphincteroplasty, magnetic anal sphincter, or implantation of an artificial anal sphincter may be considered. Only in patients that have exhausted all non-invasive and invasive options is a colostomy offered for recalcitrant fecal incontinence.
The best remedy for any complication is prevention. One way to prevent incontinence is by minimizing the number of procedures a patient requires for his or her fistula and tailoring therapy for high-risk patients. Counseling patients preoperatively on the risks of fecal incontinence and obtained preoperative anal manometry are all useful for stratifying patients preoperatively. Obtaining preoperative imaging to classify fistulas before surgery more accurately should be considered as well.
Anal abscesses are a common condition and may result in anal fistula in up to 40% of cases, and the majority of anorectal fistulas are cryptoglandular in origin. Prevention of anal abscesses will likely, therefore, decrease anal fistula. Patient education on a healthy diet and exercise to prevent diabetes is an essential component of this. Since anorectal sexually transmitted infections may cause anorectal fistula education about safe sex practices, particularly in the homosexual community, it is a necessary aspect of preventing these diseases.
Educating the general public on the warning signs of Crohn disease, such as weight loss, abdominal pain, bloody diarrhea, or extra-intestinal manifestations, may aid early diagnosis of Crohn disease and, hopefully, with proper medical management, decrease the suffering of this patient population with anal fistula. Expanding access to healthcare is essential to prevent complications of anal abscess as untreated abscesses are more likely to result in a fistula. Educating patients on proper hygiene and skincare of the perianal region, such as showering daily and washing when soiled, may also help prevent this morbid condition.
Patient-centered care involves the patient in preoperative discussion in proposed decision making. Educating patients preoperatively may aid in decision making to manage post-operative expectations. General Surgeons see and manage the majority of patients with anal fistula; however, involving a colorectal surgeon in complex cases is essential as they are trained more specifically in these conditions than the general surgeon. For example, ACGME requirements for graduation of general surgery residents only require a total of 20 anorectal procedures, however, accredited colorectal surgery fellowships require a total of 60 anorectal procedures including 20 fistula procedures.
Colorectal surgeons are also trained in the treatment of fecal incontinence and thus are better equipped to diagnose and treat this potentially preventable complication. There is evidence that the care of anal fistulas in patients with Crohn disease is improved when a multidisciplinary team is utilized as these patients often have difficulty obtaining their required medications and other issues with care. Coordination of primary care providers with specialists is important in coordinating care for these patients as well as for early diagnosis of anal fistula.
A Cochrane review published in 2010 showed the concomitant fistula treatment at the time of incision and drainage of abscess decreased persistence of fistula or abscess without an increase in complications. There is a shortage of evidence of comprehensive care for fistulas that are not secondary to Crohn disease, but with improved imaging techniques and the knowledge that MRI may change operative outcomes, coordination between surgeons and radiologists is becoming essential in effective planning for patients with complex disease.
|||PARKS AG, Pathogenesis and treatment of fistuila-in-ano. British medical journal. 1961 Feb 18; [PubMed PMID: 13732880]|
|||Hämäläinen KP,Sainio AP, Incidence of fistulas after drainage of acute anorectal abscesses. Diseases of the colon and rectum. 1998 Nov; [PubMed PMID: 9823799]|
|||Scoma JA,Salvati EP,Rubin RJ, Incidence of fistulas subsequent to anal abscesses. Diseases of the colon and rectum. 1974 May-Jun; [PubMed PMID: 4830804]|
|||Sainio P, Fistula-in-ano in a defined population. Incidence and epidemiological aspects. Annales chirurgiae et gynaecologiae. 1984; [PubMed PMID: 6508203]|
|||Owen HA,Buchanan GN,Schizas A,Cohen R,Williams AB, Quality of life with anal fistula. Annals of the Royal College of Surgeons of England. 2016 May; [PubMed PMID: 27087327]|
|||Parks AG,Gordon PH,Hardcastle JD, A classification of fistula-in-ano. The British journal of surgery. 1976 Jan; [PubMed PMID: 1267867]|
|||Xu Y,Liang S,Tang W, Meta-analysis of randomized clinical trials comparing fistulectomy versus fistulotomy for low anal fistula. SpringerPlus. 2016; [PubMed PMID: 27777858]|
|||Morris J,Spencer JA,Ambrose NS, MR imaging classification of perianal fistulas and its implications for patient management. Radiographics : a review publication of the Radiological Society of North America, Inc. 2000 May-Jun; [PubMed PMID: 10835116]|
|||Spencer JA,Chapple K,Wilson D,Ward J,Windsor AC,Ambrose NS, Outcome after surgery for perianal fistula: predictive value of MR imaging. AJR. American journal of roentgenology. 1998 Aug; [PubMed PMID: 9694464]|
|||Mocanu V,Dang JT,Ladak F,Tian C,Wang H,Birch DW,Karmali S, Antibiotic use in prevention of anal fistulas following incision and drainage of anorectal abscesses: A systematic review and meta-analysis. American journal of surgery. 2019 May; [PubMed PMID: 30773213]|
|||Garg P,Garg M,Das BR,Khadapkar R,Menon GR, Perianal Tuberculosis: Lessons Learned in 57 Patients From 743 Samples of Histopathology and Polymerase Chain Reaction and a Systematic Review of Literature. Diseases of the colon and rectum. 2019 Nov; [PubMed PMID: 31596764]|
|||Choi YS,Kim DS,Lee JB,Kim JK,Jung HJ,Lee SD,Song KH,Lee DH,Kim MJ, Clinical Features of Tuberculous Versus Crohn's Anal Fistulas, in Korea. Journal of Crohn's [PubMed PMID: 26374663]|
|||Assi R,Hashim PW,Reddy VB,Einarsdottir H,Longo WE, Sexually transmitted infections of the anus and rectum. World journal of gastroenterology. 2014 Nov 7; [PubMed PMID: 25386074]|
|||Do NL,Nagle D,Poylin VY, Radiation proctitis: current strategies in management. Gastroenterology research and practice. 2011; [PubMed PMID: 22144997]|
|||Manookian CM,Sokol TP,Headrick C,Fleshner PR, Does HIV status influence the anatomy of anal fistulas? Diseases of the colon and rectum. 1998 Dec; [PubMed PMID: 9860334]|
|||Gonzalez-Ruiz C,Heartfield W,Briggs B,Vukasin P,Beart RW, Anorectal pathology in HIV/AIDS-infected patients has not been impacted by highly active antiretroviral therapy. Diseases of the colon and rectum. 2004 Sep; [PubMed PMID: 15486744]|
|||Signorello LB,Harlow BL,Chekos AK,Repke JT, Midline episiotomy and anal incontinence: retrospective cohort study. BMJ (Clinical research ed.). 2000 Jan 8; [PubMed PMID: 10625261]|
|||Gagnard C,Godlewski G,Prat D,Lan O,Cousineau J,Maklouf Y, The nerve branches to the external anal sphincter: the macroscopic supply and microscopic structure. Surgical and radiologic anatomy : SRA. 1986; [PubMed PMID: 3097851]|
|||Zanotti C,Martinez-Puente C,Pascual I,Pascual M,Herreros D,García-Olmo D, An assessment of the incidence of fistula-in-ano in four countries of the European Union. International journal of colorectal disease. 2007 Dec; [PubMed PMID: 17554546]|
|||Wang D,Yang G,Qiu J,Song Y,Wang L,Gao J,Wang C, Risk factors for anal fistula: a case-control study. Techniques in coloproctology. 2014 Jul; [PubMed PMID: 24452294]|
|||Devaraj B,Khabassi S,Cosman BC, Recent smoking is a risk factor for anal abscess and fistula. Diseases of the colon and rectum. 2011 Jun; [PubMed PMID: 21552051]|
|||Zheng LH,Zhang AZ,Shi YY,Li X,Jia LS,Zhi CC,Yu QX,Zhang W,Liu YJ,Wang L,Xiao D,Wang C, Impact of Smoking on Anal Abscess and Anal Fistula Diseases. Chinese medical journal. 2018 May 5; [PubMed PMID: 29692373]|
|||Ellis CN,Clark S, Effect of tobacco smoking on advancement flap repair of complex anal fistulas. Diseases of the colon and rectum. 2007 Apr; [PubMed PMID: 17195081]|
|||Hamadani A,Haigh PI,Liu IL,Abbas MA, Who is at risk for developing chronic anal fistula or recurrent anal sepsis after initial perianal abscess? Diseases of the colon and rectum. 2009 Feb; [PubMed PMID: 19279415]|
|||Wijekoon NS,Samarasekera DN, The value of routine histopathological analysis in patients with fistula in-ano. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 2010 Feb; [PubMed PMID: 19175634]|
|||Bozbora A,Erbil Y,Berber E,Ozarmağan S,Ozarmağan G, Surgical treatment of granuloma inguinale. The British journal of dermatology. 1998 Jun; [PubMed PMID: 9747380]|
|||Siddiqui MR,Ashrafian H,Tozer P,Daulatzai N,Burling D,Hart A,Athanasiou T,Phillips RK, A diagnostic accuracy meta-analysis of endoanal ultrasound and MRI for perianal fistula assessment. Diseases of the colon and rectum. 2012 May; [PubMed PMID: 22513437]|
|||Felt-Bersma RJ, Endoanal ultrasound in benign anorectal disorders: clinical relevance and possibilities. Expert review of gastroenterology [PubMed PMID: 19072406]|
|||Karanikas I,Koutserimpas C,Siaperas P,Skarpas A,Karoubalis J,Velimezis G, Transrectal ultrasonography of perianal fistulas: a single center experience from a surgeon's point of view. Il Giornale di chirurgia. 2018 Jul-Aug; [PubMed PMID: 30039796]|
|||Felt-Bersma RJ, Endoanal ultrasound in perianal fistulas and abscesses. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2006 Aug; [PubMed PMID: 16627017]|
|||Visscher AP,Felt-Bersma RJ, Endoanal ultrasound in perianal fistulae and abscesses. Ultrasound quarterly. 2015 Jun; [PubMed PMID: 25364961]|
|||Soker G,Gulek B,Yilmaz C,Kaya O,Arslan M,Dilek O,Gorur M,Kuscu F,İrkorucu O, The comparison of CT fistulography and MR imaging of perianal fistulae with surgical findings: a case-control study. Abdominal radiology (New York). 2016 Aug; [PubMed PMID: 27034072]|
|||Khati NJ,Sondel Lewis N,Frazier AA,Obias V,Zeman RK,Hill MC, CT of acute perianal abscesses and infected fistulae: a pictorial essay. Emergency radiology. 2015 Jun; [PubMed PMID: 25421387]|
|||Liang C,Jiang W,Zhao B,Zhang Y,Du Y,Lu Y, CT imaging with fistulography for perianal fistula: does it really help the surgeon? Clinical imaging. 2013 Nov-Dec; [PubMed PMID: 23958432]|
|||Baskan O,Koplay M,Sivri M,Erol C, Our Experience with MR Imaging of Perianal Fistulas. Polish journal of radiology. 2014; [PubMed PMID: 25550766]|
|||Liang C,Lu Y,Zhao B,Du Y,Wang C,Jiang W, Imaging of anal fistulas: comparison of computed tomographic fistulography and magnetic resonance imaging. Korean journal of radiology. 2014 Nov-Dec; [PubMed PMID: 25469082]|
|||Konan A,Onur MR,Özmen MN, The contribution of preoperative MRI to the surgical management of anal fistulas. Diagnostic and interventional radiology (Ankara, Turkey). 2018 Nov; [PubMed PMID: 30272562]|
|||Liu D,Li W,Wang X,Qiu J,Wang L,Xiong F,Zhou Z, [Classification of anal fistulas based on magnetic resonance imaging]. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery. 2018 Dec 25; [PubMed PMID: 30588591]|
|||Hutan M,Hutan M Jr,Satko M,Dimov A, Significance of MRI in the treatment of perianal fistula. Bratislavske lekarske listy. 2009; [PubMed PMID: 19507636]|
|||Yang BL,Gu YF,Zhu X,Shao WJ,Sun GD,Ding SQ,Jin HY, [Application of magnetic resonance imaging in the diagnosis of complex anal fistula]. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery. 2008 Jul; [PubMed PMID: 18636355]|
|||O'Malley RB,Al-Hawary MM,Kaza RK,Wasnik AP,Liu PS,Hussain HK, Rectal imaging: part 2, Perianal fistula evaluation on pelvic MRI--what the radiologist needs to know. AJR. American journal of roentgenology. 2012 Jul; [PubMed PMID: 22733931]|
|||Maccioni F,Colaiacomo MC,Stasolla A,Manganaro L,Izzo L,Marini M, Value of MRI performed with phased-array coil in the diagnosis and pre-operative classification of perianal and anal fistulas. La Radiologia medica. 2002 Jul-Aug; [PubMed PMID: 12386556]|
|||Garg P,Singh P,Kaur B, Magnetic Resonance Imaging (MRI): Operative Findings Correlation in 229 Fistula-in-Ano Patients. World journal of surgery. 2017 Jun; [PubMed PMID: 28097414]|
|||Garg P, Comparison of Preoperative and Postoperative MRI After Fistula-in-Ano Surgery: Lessons Learnt from An Audit of 1323 MRI At a Single Centre. World journal of surgery. 2019 Jun; [PubMed PMID: 30706106]|
|||Zhan S,Yang S,Lin J,Zhu Q,Lu F,Tan W,Cheng R,Gong Z,Yang W, Use of a Balloon Rectal Catheter in Magnetic Resonance Imaging of Complex Anal Fistula to Improve Detection of Internal Openings. Journal of computer assisted tomography. 2016 Jul-Aug; [PubMed PMID: 26953770]|
|||Buchanan G,Halligan S,Williams A,Cohen CR,Tarroni D,Phillips RK,Bartram CI, Effect of MRI on clinical outcome of recurrent fistula-in-ano. Lancet (London, England). 2002 Nov 23; [PubMed PMID: 12457791]|
|||Garcés-Albir M,García-Botello SA,Esclapez-Valero P,Sanahuja-Santafé A,Raga-Vázquez J,Espi-Macías A,Ortega-Serrano J, Quantifying the extent of fistulotomy. How much sphincter can we safely divide? A three-dimensional endosonographic study. International journal of colorectal disease. 2012 Aug; [PubMed PMID: 22418879]|
|||Hall JF,Bordeianou L,Hyman N,Read T,Bartus C,Schoetz D,Marcello PW, Outcomes after operations for anal fistula: results of a prospective, multicenter, regional study. Diseases of the colon and rectum. 2014 Nov; [PubMed PMID: 25285698]|
|||Farag AFA,Elbarmelgi MY,Mostafa M,Mashhour AN, One stage fistulectomy for high anal fistula with reconstruction of anal sphincter without fecal diversion. Asian journal of surgery. 2019 Aug; [PubMed PMID: 30738718]|
|||Ratto C,Litta F,Donisi L,Parello A, Fistulotomy or fistulectomy and primary sphincteroplasty for anal fistula (FIPS): a systematic review. Techniques in coloproctology. 2015 Jul; [PubMed PMID: 26062740]|
|||Murtaza G,Shaikh FA,Chawla T,Rajput BU,Shahzad N,Ansari S, Fistulotomy versus fistulectomy for simple fistula in ano: a retrospective cohort study. JPMA. The Journal of the Pakistan Medical Association. 2017 Mar; [PubMed PMID: 28303978]|
|||Pescatori M,Ayabaca SM,Cafaro D,Iannello A,Magrini S, Marsupialization of fistulotomy and fistulectomy wounds improves healing and decreases bleeding: a randomized controlled trial. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 2006 Jan; [PubMed PMID: 16519632]|
|||Belmonte Montes C,Ruiz Galindo GH,Montes Villalobos JL,Decanini Terán C, [Fistulotomy vs fistulectomy. Ultrasonographic evaluation of lesion of the anal sphincter function]. Revista de gastroenterologia de Mexico. 1999 Oct-Dec; [PubMed PMID: 10851578]|
|||Toyonaga T,Matsushima M,Tanaka Y,Suzuki K,Sogawa N,Kanyama H,Shimojima Y,Hatakeyama T,Tanaka M, Non-sphincter splitting fistulectomy vs conventional fistulotomy for high trans-sphincteric fistula-in-ano: a prospective functional and manometric study. International journal of colorectal disease. 2007 Sep; [PubMed PMID: 17294195]|
|||Ortiz H,Marzo M,de Miguel M,Ciga MA,Oteiza F,Armendariz P, Length of follow-up after fistulotomy and fistulectomy associated with endorectal advancement flap repair for fistula in ano. The British journal of surgery. 2008 Apr; [PubMed PMID: 18161890]|
|||Mylonakis E,Katsios C,Godevenos D,Nousias B,Kappas AM, Quality of life of patients after surgical treatment of anal fistula; the role of anal manometry. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 2001 Nov; [PubMed PMID: 12790941]|
|||Ratto C,Grossi U,Litta F,Di Tanna GL,Parello A,De Simone V,Tozer P,DE Zimmerman D,Maeda Y, Contemporary surgical practice in the management of anal fistula: results from an international survey. Techniques in coloproctology. 2019 Aug; [PubMed PMID: 31368010]|
|||Kelly ME,Heneghan HM,McDermott FD,Nason GJ,Freeman C,Martin ST,Winter DC, The role of loose seton in the management of anal fistula: a multicenter study of 200 patients. Techniques in coloproctology. 2014 Oct; [PubMed PMID: 24989839]|
|||Daodu OO,O'Keefe J,Heine JA, Draining Setons as Definitive Management of Fistula-in-Ano. Diseases of the colon and rectum. 2018 Apr; [PubMed PMID: 29521832]|
|||Theerapol A,So BY,Ngoi SS, Routine use of setons for the treatment of anal fistulae. Singapore medical journal. 2002 Jun; [PubMed PMID: 12380728]|
|||Rosen DR,Kaiser AM, Definitive seton management for transsphincteric fistula-in-ano: harm or charm? Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 2016 May; [PubMed PMID: 26382283]|
|||Patton V,Chen CM,Lubowski D, Long-term results of the cutting seton for high anal fistula. ANZ journal of surgery. 2015 Oct; [PubMed PMID: 25997475]|
|||Takesue Y,Ohge H,Yokoyama T,Murakami Y,Imamura Y,Sueda T, Long-term results of seton drainage on complex anal fistulae in patients with Crohn's disease. Journal of gastroenterology. 2002; [PubMed PMID: 12483246]|
|||Shirah BH,Shirah HA, The Impact of the Outcome of Treating a High Anal Fistula by Using a Cutting Seton and Staged Fistulotomy on Saudi Arabian Patients. Annals of coloproctology. 2018 Oct; [PubMed PMID: 30304930]|
|||Subhas G,Gupta A,Balaraman S,Mittal VK,Pearlman R, Non-cutting setons for progressive migration of complex fistula tracts: a new spin on an old technique. International journal of colorectal disease. 2011 Jun; [PubMed PMID: 21431319]|
|||Emile SH,Elfeki H,Thabet W,Sakr A,Magdy A,El-Hamed TMA,Omar W,Khafagy W, Predictive factors for recurrence of high transsphincteric anal fistula after placement of seton. The Journal of surgical research. 2017 Jun 1; [PubMed PMID: 28601324]|
|||Dziki A,Bartos M, Seton treatment of anal fistula: experience with a new modification. The European journal of surgery = Acta chirurgica. 1998 Jul; [PubMed PMID: 9696978]|
|||Vial M,Parés D,Pera M,Grande L, Faecal incontinence after seton treatment for anal fistulae with and without surgical division of internal anal sphincter: a systematic review. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 2010 Mar; [PubMed PMID: 19220371]|
|||Altomare DF,Greco VJ,Tricomi N,Arcanà F,Mancini S,Rinaldi M,Pulvirenti d'Urso A,La Torre F, Seton or glue for trans-sphincteric anal fistulae: a prospective randomized crossover clinical trial. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 2011 Jan; [PubMed PMID: 19832873]|
|||Tan KK,Alsuwaigh R,Tan AM,Tan IJ,Liu X,Koh DC,Tsang CB, To LIFT or to flap? Which surgery to perform following seton insertion for high anal fistula? Diseases of the colon and rectum. 2012 Dec; [PubMed PMID: 23135586]|
|||Rojanasakul A,Pattanaarun J,Sahakitrungruang C,Tantiphlachiva K, Total anal sphincter saving technique for fistula-in-ano; the ligation of intersphincteric fistula tract. Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 2007 Mar; [PubMed PMID: 17427539]|
|||Kang WH,Yang HK,Chang HJ,Ko YT,Yoo BE,Lim CH,Hwang JK,Lee YC,Shin HK,Son HJ, High ligation of the anal fistula tract by lateral approach: A prospective cohort study on a modification of the ligation of the intersphincteric fistula tract (LIFT) technique. International journal of surgery (London, England). 2018 Dec; [PubMed PMID: 30343130]|
|||Emile SH,Khan SM,Adejumo A,Koroye O, Ligation of intersphincteric fistula tract (LIFT) in treatment of anal fistula: An updated systematic review, meta-analysis, and meta-regression of the predictors of failure. Surgery. 2020 Feb; [PubMed PMID: 31648932]|
|||Stellingwerf ME,van Praag EM,Tozer PJ,Bemelman WA,Buskens CJ, Systematic review and meta-analysis of endorectal advancement flap and ligation of the intersphincteric fistula tract for cryptoglandular and Crohn's high perianal fistulas. BJS open. 2019 Jun; [PubMed PMID: 31183438]|
|||Osterkamp J,Gocht-Jensen P,Hougaard K,Nordentoft T, Long-term outcomes in patients after ligation of the intersphincteric fistula tract. Danish medical journal. 2019 Apr; [PubMed PMID: 30910002]|
|||Vergara-Fernandez O,Espino-Urbina LA, Ligation of intersphincteric fistula tract: what is the evidence in a review? World journal of gastroenterology. 2013 Oct 28; [PubMed PMID: 24187455]|
|||Podetta M,Scarpa CR,Zufferey G,Skala K,Ris F,Roche B,Buchs NC, Correction to: Mucosal advancement flap for recurrent complex anal fistula: a repeatable procedure. International journal of colorectal disease. 2019 Mar; [PubMed PMID: 30570673]|
|||Yellinek S,Krizzuk D,Moreno Djadou T,Lavy D,Wexner SD, Endorectal advancement flap for complex anal fistula: does flap configuration matter? Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 2019 May; [PubMed PMID: 30673146]|
|||Rottoli M,Di Simone MP,Poggioli G, TAMIS-Flap Technique: Full-thickness Advancement Rectal Flap for High Perianal Fistulae Performed Through Transanal Minimally Invasive Surgery. Surgical laparoscopy, endoscopy [PubMed PMID: 31259866]|
|||Jafarzadeh J,Najibpoor N,Salmasi A, A comparative study on the effectiveness of rectal advancement flap and seton placement surgeries in patients with anal fistula on the rate of recurrence, incontinence and infection. Journal of family medicine and primary care. 2019 Nov; [PubMed PMID: 31803658]|
|||Dubsky PC,Stift A,Friedl J,Teleky B,Herbst F, Endorectal advancement flaps in the treatment of high anal fistula of cryptoglandular origin: full-thickness vs. mucosal-rectum flaps. Diseases of the colon and rectum. 2008 Jun; [PubMed PMID: 18317841]|
|||Khafagy W,Omar W,El Nakeeb A,Fouda E,Yousef M,Farid M, Treatment of anal fistulas by partial rectal wall advancement flap or mucosal advancement flap: a prospective randomized study. International journal of surgery (London, England). 2010; [PubMed PMID: 20388562]|
|||Soltani A,Kaiser AM, Endorectal advancement flap for cryptoglandular or Crohn's fistula-in-ano. Diseases of the colon and rectum. 2010 Apr; [PubMed PMID: 20305451]|
|||Bessi G,Siproudhis L,Merlini l'Héritier A,Wallenhorst T,Le Balc'h E,Bouguen G,Brochard C, Advancement flap procedure in Crohn and non-Crohn perineal fistulas: a simple surgical approach. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 2019 Jan; [PubMed PMID: 30199606]|
|||van Onkelen RS,Gosselink MP,Thijsse S,Schouten WR, Predictors of outcome after transanal advancement flap repair for high transsphincteric fistulas. Diseases of the colon and rectum. 2014 Aug; [PubMed PMID: 25003296]|
|||Khanduja KS,Padmanabhan A,Kerner BA,Wise WE,Aguilar PS, Reconstruction of rectovaginal fistula with sphincter disruption by combining rectal mucosal advancement flap and anal sphincteroplasty. Diseases of the colon and rectum. 1999 Nov; [PubMed PMID: 10566531]|
|||Jayne DG,Scholefield J,Tolan D,Gray R,Edlin R,Hulme CT,Sutton AJ,Handley K,Hewitt CA,Kaur M,Magill L, Anal fistula plug versus surgeon's preference for surgery for trans-sphincteric anal fistula: the FIAT RCT. Health technology assessment (Winchester, England). 2019 May; [PubMed PMID: 31113531]|
|||Tao Y,Han JG,Wang ZJ,Zheng Y,Cui JJ,Zhao BC,Yang XQ, [Long-term efficacy of bioprosthetic anal fistula plug in the treatment of transsphincteric anal fistula]. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery. 2020 Jan 25; [PubMed PMID: 31958934]|
|||Adamina M,Ross T,Guenin MO,Warschkow R,Rodger C,Cohen Z,Burnstein M, Anal fistula plug: a prospective evaluation of success, continence and quality of life in the treatment of complex fistulae. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 2014 Jul; [PubMed PMID: 24521307]|
|||Safar B,Jobanputra S,Sands D,Weiss EG,Nogueras JJ,Wexner SD, Anal fistula plug: initial experience and outcomes. Diseases of the colon and rectum. 2009 Feb; [PubMed PMID: 19279419]|
|||Herold A,Ommer A,Fürst A,Pakravan F,Hahnloser D,Strittmatter B,Schiedeck T,Hetzer F,Aigner F,Berg E,Roblick M,Bussen D,Joos A,Vershenya S, Results of the Gore Bio-A fistula plug implantation in the treatment of anal fistula: a multicentre study. Techniques in coloproctology. 2016 Aug; [PubMed PMID: 27418257]|
|||Bondi J,Avdagic J,Karlbom U,Hallböök O,Kalman D,Šaltytė Benth J,Naimy N,Øresland T, Randomized clinical trial comparing collagen plug and advancement flap for trans-sphincteric anal fistula. The British journal of surgery. 2017 Aug; [PubMed PMID: 28489253]|
|||Lawes DA,Efron JE,Abbas M,Heppell J,Young-Fadok TM, Early experience with the bioabsorbable anal fistula plug. World journal of surgery. 2008 Jun; [PubMed PMID: 18373120]|
|||Adamina M,Hoch JS,Burnstein MJ, To plug or not to plug: a cost-effectiveness analysis for complex anal fistula. Surgery. 2010 Jan; [PubMed PMID: 19733880]|
|||Senéjoux A,Siproudhis L,Abramowitz L,Munoz-Bongrand N,Desseaux K,Bouguen G,Bourreille A,Dewit O,Stefanescu C,Vernier G,Louis E,Grimaud JC,Godart B,Savoye G,Hebuterne X,Bauer P,Nachury M,Laharie D,Chevret S,Bouhnik Y, Fistula Plug in Fistulising Ano-Perineal Crohn's Disease: a Randomised Controlled Trial. Journal of Crohn's [PubMed PMID: 26351393]|
|||Liu H,Tang X,Chang Y,Li A,Li Z,Xiao Y,Zhang Y,Pan Z,Lv L,Lin M,Yin L,Jiang H, Comparison of surgical outcomes between video-assisted anal fistula treatment and fistulotomy plus seton for complex anal fistula: A propensity score matching analysis - Retrospective cohort study. International journal of surgery (London, England). 2020 Mar; [PubMed PMID: 32014596]|
|||Lee MJ,Freer C,Adegbola S,Elkady S,Parkes M,Hart A,Fearnhead NS,Lobo AJ,Brown SR, Patients with perianal Crohn's fistulas experience delays in accessing anti-TNF therapy due to slow recognition, diagnosis and integration of specialist services: lessons learned from three referral centres. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 2018 Sep; [PubMed PMID: 29569419]|
|||Strik AS,Löwenberg M,Buskens CJ,B Gecse K,I Ponsioen C,Bemelman WA,D'Haens GR, Higher anti-TNF serum levels are associated with perianal fistula closure in Crohn's disease patients. Scandinavian journal of gastroenterology. 2019 Apr; [PubMed PMID: 31032686]|
|||Yarur AJ,Kanagala V,Stein DJ,Czul F,Quintero MA,Agrawal D,Patel A,Best K,Fox C,Idstein K,Abreu MT, Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn's disease. Alimentary pharmacology [PubMed PMID: 28211593]|
|||Oliveira IS,Kilcoyne A,Price MC,Harisinghani M, MRI features of perianal fistulas: is there a difference between Crohn's and non-Crohn's patients? Abdominal radiology (New York). 2017 Apr [PubMed PMID: 27885389]|
|||Shenoy-Bhangle A,Nimkin K,Goldner D,Bradley WF,Israel EJ,Gee MS, MRI predictors of treatment response for perianal fistulizing Crohn disease in children and young adults. Pediatric radiology. 2014 Jan; [PubMed PMID: 24005981]|
|||Topstad DR,Panaccione R,Heine JA,Johnson DR,MacLean AR,Buie WD, Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience. Diseases of the colon and rectum. 2003 May; [PubMed PMID: 12792431]|
|||Hukkinen M,Pakarinen MP,Piekkala M,Koivusalo A,Rintala R,Kolho KL, Treatment of complex perianal fistulas with seton and infliximab in adolescents with Crohn's disease. Journal of Crohn's [PubMed PMID: 24447625]|
|||de Groof EJ,Sahami S,Lucas C,Ponsioen CY,Bemelman WA,Buskens CJ, Treatment of perianal fistula in Crohn's disease: a systematic review and meta-analysis comparing seton drainage and anti-tumour necrosis factor treatment. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 2016 Jul; [PubMed PMID: 26921847]|
|||Kazal HL,Sohn N,Carrasco JI,Robilotti JG,Delaney WE, The gay bowel syndrome: clinico-pathologic correlation in 260 cases. Annals of clinical and laboratory science. 1976 Mar-Apr; [PubMed PMID: 946385]|
|||Schulberg S,Al-Feghali V,Bain K,Shehebar J, Non-cutaneous AIDS-associated Kaposi's sarcoma presenting as recurrent rectal abscesses. BMJ case reports. 2018 Aug 20; [PubMed PMID: 30131417]|
|||Isfahani F,Amar S,Dave H,Gridley D, Plasmoblastic lymphoma as cause of perianal fistula: a case report and literature review. Journal of the International Association of Providers of AIDS Care. 2015 Jan-Feb; [PubMed PMID: 25320144]|
|||Mizrahi N,Wexner SD,Zmora O,Da Silva G,Efron J,Weiss EG,Vernava AM 3rd,Nogueras JJ, Endorectal advancement flap: are there predictors of failure? Diseases of the colon and rectum. 2002 Dec; [PubMed PMID: 12473884]|
|||Wright M,Thorson A,Blatchford G,Shashidharan M,Beaty J,Bertelson N,Aggrawal P,Taylor L,Ternent CA, What happens after a failed LIFT for anal fistula? American journal of surgery. 2017 Dec; [PubMed PMID: 29146001]|
|||Giarratano G,Shalaby M,Toscana C,Sileri P, Video-assisted anal fistula treatment for complex anal fistula: a long-term follow-up study. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 2020 Feb 6; [PubMed PMID: 32030874]|
|||Mei Z,Wang Q,Zhang Y,Liu P,Ge M,Du P,Yang W,He Y, Risk Factors for Recurrence after anal fistula surgery: A meta-analysis. International journal of surgery (London, England). 2019 Sep; [PubMed PMID: 31400504]|
|||Abbas MA,Jackson CH,Haigh PI, Predictors of outcome for anal fistula surgery. Archives of surgery (Chicago, Ill. : 1960). 2011 Sep; [PubMed PMID: 21930996]|
|||Jordán J,Roig JV,García-Armengol J,García-Granero E,Solana A,Lledó S, Risk factors for recurrence and incontinence after anal fistula surgery. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 2010 Mar; [PubMed PMID: 19220375]|
|||Toyonaga T,Matsushima M,Kiriu T,Sogawa N,Kanyama H,Matsumura N,Shimojima Y,Hatakeyama T,Tanaka Y,Suzuki K,Tanaka M, Factors affecting continence after fistulotomy for intersphincteric fistula-in-ano. International journal of colorectal disease. 2007 Sep; [PubMed PMID: 17262199]|
|||Bharucha AE,Rao SSC,Shin AS, Surgical Interventions and the Use of Device-Aided Therapy for the Treatment of Fecal Incontinence and Defecatory Disorders. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2017 Dec; [PubMed PMID: 28838787]|
|||Gecse KB,Bemelman W,Kamm MA,Stoker J,Khanna R,Ng SC,Panés J,van Assche G,Liu Z,Hart A,Levesque BG,D'Haens G, A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease. Gut. 2014 Sep; [PubMed PMID: 24951257]|